EP4095130
Merktir hindrar fyrir blöðruhálskirtilssértækan himnu-mótefnavaka (psma), notkun þeirra sem myndgerðarmiðlar og lyfjamiðlar til meðhöndlunar á krabbameini í blöðruhálskirtli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.10.2014EP published:
31.1.2024EP application number:
22178736.9
EP translation filed:
15.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
16.10.2034Expiry date:
16.10.2026Next due date:
31.10.2026
Title in English:
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCERLanguage of the patent:
English
Timeline
Today
17.10.2014EP application
31.1.2024EP Publication
15.4.2024Translation submitted
15.5.2024Registration published
16.10.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
EDER, MatthiasAddress:
68239 Mannheim, DE
Name:
KOPKA, KlausAddress:
69221 Dossenheim, DE
Name:
SCHÄFER, MartinAddress:
69239 Neckarsteinach, DE
Name:
BAUDER-WÜST, UlrikeAddress:
69198 Schriesheim, DE
Name:
HABERKORN, UweAddress:
68723 Schwetzingen, DE
Name:
BENESOVA, MartinaAddress:
69239 Neckarsteinach, DE
Name:
MIER, WalterAddress:
64625 Bensheim, DE
Name:
KLIEM, Hans-ChristianAddress:
64646 Heppenheim, DE
Name:
KRATOCHWIL, ClemensAddress:
69120 Heidelberg, DE
Name:
EISENHUT, MichaelAddress:
Heidelberg 69118, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13004991Date:
18.10.2013Country:
EP
Number:
14175612Date:
3.7.2014Country:
EP
Supplementary protection
SPC number:
SPC475
Classification
Categories:
C07D 295/145, C07B 59/00, A61K 51/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 23.9.2024
Expires: 16.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 2.10.2025
Expires: 16.10.2026
Payer: Árnason Faktor ehf.